SCHEMBL8733294

SCHEMBL8733294

CCOC(=O)CN1C(=O)/C(=C\C=C\c2ccccc2)S/C1=N/N=C\C=C\c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.56
▸ MEN1 O00255 7/20 0.56
▸ KMT2A Q03164 7/20 0.56
▸ ALDH1A1 P00352 5/20 0.56
▸ RAB9A P51151 4/20 0.56
▸ HTT P42858 4/20 0.56
▸ NPC1 O15118 3/20 0.56
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ RECQL P46063 2/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ THRB P10828 1/20 0.56
▸ BLM P54132 1/20 0.56
▸ AKR1B1 P15121 1/20 0.50
▸ ITGB2 P05107 1/20 0.47
▸ ITGAM P11215 1/20 0.47
▸ PSMB8 P28062 1/20 0.46
▸ MMP1 P03956 1/20 0.46
▸ MMP2 P08253 1/20 0.46
▸ MMP13 P45452 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8733295 1.00 MAPT (0.56) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL8733003 0.88 MAPT (0.65) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL8733001 0.88 MAPT (0.65) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL8729720 0.80 MMP1 (0.70) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL8729717 0.80 MMP1 (0.70) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL8727681 0.78 MMP1 (0.64) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL8727675 0.78 MMP1 (0.64) MAPTMEN1KMT2AALDH1A1RAB9A
SCHEMBL21783127 0.69 PPARG (0.81) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL28374629 0.69 PPARG (0.81) MAPTMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL9177056 0.69 MAPT (0.41) MAPTMEN1KMT2AALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998043649-A2 AGE PRODUCTION INHIBITORY COMPOSITION COMPRISING A MAILLARD REACTION INHIBITOR AND VITAMIN B¿6? OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-10-08 — — WO disclosed
US-5422360-A Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-06-06 — — US disclosed
EP-0531812-A1 Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-03-17 — — EP disclosed
Send feedback